Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified …

GL Bakris, PA Sarafidis, MR Weir, B Dahlöf, B Pitt… - The Lancet, 2010 - thelancet.com
Summary Background The Avoiding Cardiovascular Events through Combination Therapy
in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial …
被引用次数：721 相关文章

[引用][C] Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a …

B GL - Lancet, 2010 - cir.nii.ac.jp
Renal outcomes with different fixed-dose combination therapies in patients with hypertension
at high risk for cardiovascular events (ACCOMPLISH) : a prespecified secondary analysis of a …

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified …

GL Bakris, PA Sarafidis, MR Weir, B Dahlöf, B Pitt… - The Lancet, 2010 - Elsevier
BACKGROUND: The Avoiding Cardiovascular Events through Combination Therapy in
Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial …

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified …

GL Bakris, PA Sarafidis, MR Weir, B Dahlöf, B Pitt… - 2010 - pubmed.ncbi.nlm.nih.gov
Background The Avoiding Cardiovascular Events through Combination Therapy in Patients
Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial antihypertensive …
[PDF] a4m.com

[PDF][PDF] Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a …

GL Bakris, PA Sarafidis, MR Weir, B Dahlöf, B Pitt… - Lancet, 2010 - a4m.com
Summary Background The Avoiding Cardiovascular Events through Combination Therapy
in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial …

[引用][C] Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a …

Accomplish Trial Investigators - Lancet, 2010 - researchportal.tuni.fi
Renal outcomes with different fixed-dose combination therapies in patients with hypertension
at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a …

[引用][C] Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a …

GL BAKRIS, PA SARAFIDIS, YT CHIANG… - Lancet (British …, 2010 - pascal-francis.inist.fr
Renal outcomes with different fixed-dose combination therapies in patients with
hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified …

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified …

GL Bakris, PA Sarafidis, MR Weir, B Dahlöf, B Pitt… - The Lancet, 2010 - thelancet.com
Summary Background The Avoiding Cardiovascular Events through Combination Therapy
in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial …
[PDF] academia.edu

[PDF][PDF] Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a …

GL Bakris, PA Sarafidis, MR Weir, B Dahlöf, B Pitt… - Lancet, 2010 - academia.edu
Summary Background The Avoiding Cardiovascular Events through Combination Therapy
in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial …

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified …

GL Bakris, PA Sarafidis, MR Weir, B Dahlöf, B Pitt… - The Lancet, 2010 - infona.pl
The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with
Systolic Hypertension (ACCOMPLISH) trial showed that initial antihypertensive therapy with …